Fertility preservation in pre-pubertal girls with cancer: the role of ovarian tissue cryopreservation  W. Hamish B. Wallace, M.D., Thomas W. Kelsey, Ph.D.,

Slides:



Advertisements
Similar presentations
Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States  David B. Seifer, M.D., Valerie.
Advertisements

Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,
Effects of cancer treatment on ovarian function
Figure 1. The solution of the Faddy–Gosden differential equation for the primordial follicle population from birth to menopause. The primordial follicle.
Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss.
Fertility preservation in pre-pubertal girls with cancer: the role of ovarian tissue cryopreservation  W. Hamish B. Wallace, M.D., Thomas W. Kelsey, Ph.D.,
Volume 15, Issue 10, Pages (September 2014)
Age at menarche: a predictor of diminished ovarian function?
External validation of nomogram for the decline in serum anti-Müllerian hormone in women: a population study of 15,834 infertility patients  Scott M.
Karl R. Hansen, M. D. , Ph. D. , George M. Hodnett, M. D
The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition  Lorraine Dennerstein,
Long-term risk of ectopic pregnancy varies by method of tubal sterilization: a whole- population study  Eva Malacova, Ph.D., Anna Kemp, Ph.D., Roger Hart,
The predictive value for in vitro fertility delivery rates is greatly impacted by the method used to select the threshold between normal and elevated.
Ovarian cryopreservation and transplantation for fertility preservation for medical indications: report of an ongoing experience  Kutluk Oktay, M.D.,
Janet Kwee, M. D. , Roel Schats, M. D. , Ph. D. , Joseph McDonnell, M
Patient-tailored ovarian stimulation for in vitro fertilization
Antimüllerian hormone: correlation with age and androgenic and metabolic factors in women from birth to postmenopause  Linlin Cui, M.D., Ph.D., Yingying.
Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women  Carlos Iglesias, M.D., Manish Banker, M.D.,
Contribution of the rate of change of antimüllerian hormone in estimating time to menopause for late reproductive-age women  Ellen W. Freeman, Ph.D.,
Antimüllerian hormone levels and antral follicle count as prognostic indicators in a personalized prediction model of live birth  Scott M. Nelson, M.R.C.O.G.,
Antimüllerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for.
Temporal trends in clomiphene citrate use: a population-based study
Surgical arrows should be identified on the cyst wall
Antimüllerian hormone levels and antral follicle counts are not reduced compared with community controls in patients with rigorously defined unexplained.
The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count  Simone L. Broer, B.Sc., Ben Willem J.
Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D
Elevated body mass index is associated with lower serum anti-mullerian hormone levels in infertile women with diminished ovarian reserve but not with.
Ellen W. Freeman, Ph. D. , Clarisa R. Gracia, M. D. , Mary D
Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss.
A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data 
Oocyte cryopreservation
Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine.
Deleterious effect of tobacco on IVF outcome and ovarian reserve as reflected by serum anti mullerian hormone (AMH)  P. Barriere, T. Freour, D. Masson,
Modification of the Beckman-Coulter second-generation enzyme-linked immunosorbent assay protocol improves the reliability of serum antimüllerian hormone.
Robert F. Casper, M.D.  Fertility and Sterility 
Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling.
Dynamic antimüllerian hormone levels during controlled ovarian hyperstimulation predict in vitro fertilization response and pregnancy outcomes  Aaron.
Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic.
W.H. Wallace, T.W. Kelsey, R.A. Anderson 
Tomer Singer, M. D. , David H. Barad, M. D. , M. S
Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis  Reshef Tal,
Mitchell P. Rosen, M. D. , Erica Johnstone, M. D. , Charles E
Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D. 
Antimüllerian hormone and antral follicle count are lower in female cancer survivors and healthy women taking hormonal contraception  Lauren N.C. Johnson,
Current approach to fertility preservation by embryo cryopreservation
Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities.
Effects of cancer treatment on ovarian function
Prospective cohort study of three- versus two-dimensional ultrasound for prediction of oocyte maturity  Doron Shmorgun, M.D., Edward Hughes, M.D., Patrick.
Ri-Cheng Chian, Ph.D., Peter S. Uzelac, M.D., Geeta Nargund, M.D. 
Clinical uses of anti-Müllerian hormone assays: pitfalls and promises
Fertility preservation in girls with Turner syndrome: limitations, current success and future prospects  Kutluk Oktay, M.D., Ph.D., Giuliano Bedoschi,
Effect of first line cancer treatment on the ovarian reserve and follicular density in girls under the age of 18 years  Meryam El Issaoui, M.D., Veronica.
S. Samuel Kim, M.D.  Fertility and Sterility 
Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis.
The menopausal transition
Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,
Serum levels of antimüllerian hormone in early maturing girls before, during, and after suppression with GnRH agonist  Casper P. Hagen, M.D., Kaspar Sørensen,
A critique of the Women’s Health Initiative hormone therapy study
One-year follow-up of serum antimüllerian hormone levels in patients with cystectomy: are different sequential changes due to different mechanisms causing.
Assessing the reproductive competence of individual embryos: a proposal for the validation of new “-omics” technologies  Richard T. Scott, M.D., H.C.L.D.,
A woman with premature ovarian failure induced by Tripterygium wilfordii Hook.f. gives birth to a healthy child  Xin Chen, M.D., M.Sc., Shi-ling Chen,
Nomogram for the decline in serum antimüllerian hormone: a population study of 9,601 infertility patients  Scott M. Nelson, Ph.D., Martina C. Messow,
The play of chance Fertility and Sterility
Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function  David H. Barad, M.D., M.S., Andrea Weghofer,
Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories  Melissa C. Yih, M.D.,
Cem Fiçicioǧlu, M. D. , Tayfun Kutlu, M. D. , Elif Baglam, M. D
Bárbara Oriol, M. D. , Ana Barrio, M. D. , Alberto Pacheco, Ph. D
Ovarian follicular volume and follicular surface area are better indicators of follicular growth and maturation, respectively, than is follicular diameter 
Comparisons of inhibin B versus antimüllerian hormone in poor ovarian responders undergoing in vitro fertilization  Rongrong Tan, M.M.Sc., Danhua Pu,
The cumulative probability of liveborn multiples after in vitro fertilization: a cohort study of more than 10,000 women  Beth A. Malizia, M.D., Laura.
Presentation transcript:

Fertility preservation in pre-pubertal girls with cancer: the role of ovarian tissue cryopreservation  W. Hamish B. Wallace, M.D., Thomas W. Kelsey, Ph.D., Richard A. Anderson, M.D.  Fertility and Sterility  Volume 105, Issue 1, Pages 6-12 (January 2016) DOI: 10.1016/j.fertnstert.2015.11.041 Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Normative model for non-growing follicle (NGF) population. The best model for the establishment of the non-growing follicle population after conception, and the subsequent decline until age at menopause. CI = confidence interval. Reprinted with permission (19). Fertility and Sterility 2016 105, 6-12DOI: (10.1016/j.fertnstert.2015.11.041) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Rates of non-growing follicle (NGF) recruitment towards maturation. Illustrations of the absolute number of NGFs recruited per month, for ages from birth to 55 years, based on population decline predicted by the Asymmetric Double-Gaussian Cumulative model. (A) Recruitment for individuals whose decline is in line with the average age at menopause; maximum recruitment of 880 follicles per month occurs at 14 years 2 months. (B) Recruitment for individuals whose decline is in line with early age at menopause (the lower 95% prediction limit of the model); maximum recruitment of 104 follicles per month occurs at 14 years 2 months. (C) Recruitment in line with late age at menopause (the upper 95% prediction limit of the model); maximum recruitment of 7,520 follicles per month occurs at 14 years 2 months. Reprinted with permission (19). Fertility and Sterility 2016 105, 6-12DOI: (10.1016/j.fertnstert.2015.11.041) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions

Figure 3 The normal range for serum antimüllerian hormone (AMH) in girls and women. Red line, the log-unadjusted validated AMH model using Immunotech Beckman Coulter assay values. Blue line and green line, the 68% and 95% prediction limits for the model (plus and minus one and two standard deviations respectively). Reprinted with permission (21). Fertility and Sterility 2016 105, 6-12DOI: (10.1016/j.fertnstert.2015.11.041) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions

Figure 4 Cumulative probabilities of not having premature ovarian insufficiency. Reprinted with permission (40). Fertility and Sterility 2016 105, 6-12DOI: (10.1016/j.fertnstert.2015.11.041) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions